ALEXANDRA DILUZIO: Open Payments
NPI 1437573722 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$877 in 36 payments from 12 companies in 2025. Trend: 2023 $587 · 2024 $628 · 2025 $877
Food & beverage: $877
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 10 | $249 |
| Gilead Sciences, Inc. | 8 | $242 |
| Merck Sharp & Dohme LLC | 4 | $97 |
| ABBVIE INC. | 3 | $61 |
| Melinta Therapeutics, LLC | 2 | $53 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 2 | $34 |
| Shionogi Inc | 1 | $23 |
| Ferring Pharmaceuticals Inc. | 1 | $21 |
| Theratechnologies Inc. | 1 | $20 |
Products named: CABENUVA, APRETUDE, Rezzayo, ZERBAXA, NUZYRA, DOVATO, Biktarvy, EMBLAVEO.
Industry payments across GA — which companies pay providers there.
